Literature DB >> 3033150

Alterations in lipid metabolism, Na+,K+-ATPase activity, and tissue water content of spinal cord following experimental traumatic injury.

A I Faden, P H Chan, S Longar.   

Abstract

Traumatic spinal cord injury has recently been shown to cause a rapid increase in free fatty acids (FFAs) and lipid degradation in cats. The present studies report a more delayed, time-dependent increase in FFAs and a concomitant decrease in phospholipids following traumatic spinal injury in rats. The largest percentage increases were found for polyunsaturated fatty acids, particularly arachidonic acid. Associated with these changes were a reduction in the activity of Na+,K+-ATPase and development of spinal cord edema. These findings support the hypothesis that traumatic spinal cord injury leads to delayed, as well as early, hydrolysis of membrane phospholipids, resulting in the liberation of FFAs. Such changes may contribute to secondary spinal cord injury either through direct effects on membranes or through the actions of secondary metabolic products such as the eicosanoids. The latter may cause tissue injury by contributing to the reduction in spinal cord blood flow or through inflammatory responses that follow trauma.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3033150     DOI: 10.1111/j.1471-4159.1987.tb05740.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  15 in total

1.  Pathology dynamics predict spinal cord injury therapeutic success.

Authors:  Cassie S Mitchell; Robert H Lee
Journal:  J Neurotrauma       Date:  2008-12       Impact factor: 5.269

2.  Neuroprotective effects of ebselen on experimental spinal cord injury in rats.

Authors:  Murat Kalayci; Omer Coskun; Ferda Cagavi; Mehmet Kanter; Ferah Armutcu; Sanser Gul; Bektas Acikgoz
Journal:  Neurochem Res       Date:  2005-03       Impact factor: 3.996

3.  Fatty Acid Binding Protein 5 Modulates Docosahexaenoic Acid-Induced Recovery in Rats Undergoing Spinal Cord Injury.

Authors:  Johnny D Figueroa; Miguel Serrano-Illan; Jenniffer Licero; Kathia Cordero; Jorge D Miranda; Marino De Leon
Journal:  J Neurotrauma       Date:  2016-03-29       Impact factor: 5.269

4.  Dietary omega-3 polyunsaturated fatty acids improve the neurolipidome and restore the DHA status while promoting functional recovery after experimental spinal cord injury.

Authors:  Johnny D Figueroa; Kathia Cordero; Miguel S Llán; Marino De Leon
Journal:  J Neurotrauma       Date:  2013-02-06       Impact factor: 5.269

5.  Mapping lipid alterations in traumatically injured rat spinal cord by desorption electrospray ionization imaging mass spectrometry.

Authors:  Marion Girod; Yunzhou Shi; Ji-Xin Cheng; R Graham Cooks
Journal:  Anal Chem       Date:  2010-12-13       Impact factor: 6.986

Review 6.  Role of secretory phospholipase a(2) in CNS inflammation: implications in traumatic spinal cord injury.

Authors:  W Lee Titsworth; Nai-Kui Liu; Xiao-Ming Xu
Journal:  CNS Neurol Disord Drug Targets       Date:  2008-06       Impact factor: 4.388

7.  Free radicals in rabbit spinal cord ischemia: electron spin resonance spectroscopy and correlation with SOD activity.

Authors:  V Lombardi; L Valko; S Stolc; M Valko; O Ondrejicková; L Horáková; J Placek; A Troncone
Journal:  Cell Mol Neurobiol       Date:  1998-08       Impact factor: 5.046

8.  Efficacy of high dose amino acid solution on spinal cord injury induced by focal Nd:YAG laser irradiation.

Authors:  A Colak; G Nurlu; B Açikgöz; O E Ozcan
Journal:  Acta Neurochir (Wien)       Date:  1995       Impact factor: 2.216

9.  Palmitic and stearic fatty acids induce caspase-dependent and -independent cell death in nerve growth factor differentiated PC12 cells.

Authors:  Joel E Ulloth; Carlos A Casiano; Marino De Leon
Journal:  J Neurochem       Date:  2003-02       Impact factor: 5.372

10.  Correlation of alterations on Na(+)-K+/Mg+2 ATPase activity, lipid peroxidation and ultrastructural findings following experimental spinal cord injury with and without intravenous methylprednisolone treatment.

Authors:  F Ildan; A Oner; S Polat; T Isbir; A I Göcer; M Kaya; A Karadayi
Journal:  Neurosurg Rev       Date:  1995       Impact factor: 3.042

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.